|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-2-11
|
|
pubmed:abstractText |
Adenosine (ADO) has been shown to have beneficial effects against tissue injury after myocardial ischemia. However, the timing and dose of ADO administration have not been defined. This study was designed to determine the cardioprotective effect of exogenous ADO in an experimental open heart surgery model in pigs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1401-7431
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
409-14
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11837521-Adenosine,
pubmed-meshheading:11837521-Animals,
pubmed-meshheading:11837521-Apoptosis,
pubmed-meshheading:11837521-Cardiac Output,
pubmed-meshheading:11837521-Cardioplegic Solutions,
pubmed-meshheading:11837521-Cardiopulmonary Bypass,
pubmed-meshheading:11837521-Female,
pubmed-meshheading:11837521-Hypothermia, Induced,
pubmed-meshheading:11837521-In Situ Nick-End Labeling,
pubmed-meshheading:11837521-Ischemic Preconditioning, Myocardial,
pubmed-meshheading:11837521-Male,
pubmed-meshheading:11837521-Microspheres,
pubmed-meshheading:11837521-Swine,
pubmed-meshheading:11837521-Tumor Necrosis Factor-alpha,
pubmed-meshheading:11837521-Vasodilator Agents
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Adenosine in myocardial protection given through three windows of opportunity. An experimental study with pigs.
|
|
pubmed:affiliation |
Department of Surgery, Turku University Hospital, Finland.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
